Last reviewed · How we verify
DENV-1 PIV, 2.5 µg
At a glance
| Generic name | DENV-1 PIV, 2.5 µg |
|---|---|
| Sponsor | U.S. Army Medical Research and Development Command |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- DENV-1 PIV, 2.5 µg CI brief — competitive landscape report
- DENV-1 PIV, 2.5 µg updates RSS · CI watch RSS
- U.S. Army Medical Research and Development Command portfolio CI